How The Narrative On Advanced Enzyme Technologies (NSEI:ADVENZYMES) Is Shifting Around The ?370 Fair Value [Yahoo! Finance]
How The Advanced Enzyme Technologies (NSEI:ADVENZYMES) Story Is Shifting With An Unchanged ?370 Valuation [Yahoo! Finance]
Advantage Solutions (ADV) was downgraded by Zacks Research from "hold" to "strong sell".
Advantage Solutions (ADV) had its price target lowered by Canaccord Genuity Group Inc. from $2.50 to $1.50. They now have a "buy" rating on the stock.
Advantage Solutions (ADV) was given a new $0.75 price target by Morgan Stanley.